Chromosome 21 and down syndrome: from genomics to pathophysiology
about
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndromeConcise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic diseaseDown syndrome: searching for the genetic culpritsEmerging pharmacotherapies for neurodevelopmental disordersDisease-specific induced pluripotent stem cellsHuman microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypesDYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down SyndromeAneuploidy in stem cellsSumoylation in Synaptic Function and DysfunctionConcise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem CellsMolecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disordersGenetics of congenital heart disease: the glass half emptyDendritic spine dysgenesis in autism related disordersAneuploidy causes premature differentiation of neural and intestinal stem cellsTwo kinds of common prenatal screening tests for Down's syndrome: a systematic review and meta-analysisDown Syndrome: Current Status, Challenges and Future PerspectivesGerminal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatmentDosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndromeSynaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down's syndromeLack of sik1 in mouse embryonic stem cells impairs cardiomyogenesis by down-regulating the cyclin-dependent kinase inhibitor p57kip2Homoeologous shuffling and chromosome compensation maintain genome balance in resynthesized allopolyploid Brassica napusGeneral intelligence is associated with subclinical inflammation in Nepalese children: A population-based plasma proteomics study.A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.Visualization of repetitive DNA sequences in human chromosomes with transcription activator-like effectors.A role for sorting nexin 27 in AMPA receptor trafficking.Genetic dissection of the Down syndrome critical region.Data in brief: Transcriptome analysis of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.Understanding the basis for Down syndrome phenotypes.An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model.NF-kappaB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1.Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.A mouse embryonic stem cell bank for inducible overexpression of human chromosome 21 genes.Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse modelLowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model.Whole genome and exome sequencing of monozygotic twins with trisomy 21, discordant for a congenital heart defect and epilepsyPerturbed hematopoiesis in the Tc1 mouse model of Down syndrome.Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processesOhnologs in the human genome are dosage balanced and frequently associated with disease.
P2860
Q21136371-E8A3BF43-5F5C-484D-8B7A-2640D9A8B82CQ22241147-ABCFDA09-52F5-443B-8E7D-EEC9BBAF49AEQ22241596-FA9877FB-9CAE-467D-BA2E-39FD651E029FQ24619170-BF9E59DC-8206-4910-A771-89237ECC0B1EQ24641981-62E7D543-47A6-40ED-B65C-8E0100E62006Q24678210-E6FE0B97-FBC6-44BB-84CE-E8F3F2395439Q26745413-31E7F717-45A5-4837-9E56-38FA0A988343Q26746154-BBB3B54B-93FE-4CA2-9CF3-3F097169D75EQ26747536-F22A793D-0EE1-4885-82B5-31C8556BF488Q26799570-923EAD69-9AE1-4034-87BE-257AE39AB14CQ26853035-3F7456D9-4D98-4570-96CC-7F1AD7847C24Q26862793-617B9E68-C900-4D7A-9BF9-ECB939DC45FBQ26995242-AB50436C-2ACF-4FBB-BAE8-7518A5E615CEQ27318211-D407DF7E-D825-4358-98D0-C9222DADB83DQ28077443-4F3D9A02-FF07-41F8-9FD8-54D419402A92Q28079334-8B6B003F-0032-4132-8E29-290EE05CBA54Q28306227-AFD633AF-4768-4ACC-841F-C4E15CD39850Q28482257-C9A3F8ED-F05C-46FD-8AB0-1D802C0B66FDQ28543589-351BD691-B605-4E44-8B2A-43A865E29244Q28578459-7278A985-8976-404D-920F-258A8725237DQ28590144-439EA93A-B56B-4A15-904E-AF45DF12FC34Q28740285-A929EF18-B82A-4B79-9137-EC8464F61672Q30382506-EE402D22-60B2-493A-A834-2A01EF7CC7AFQ30495192-AA20311C-37AF-43EB-B3CC-A438FD6CBE8AQ30560977-0F1EC28D-359A-491F-A7B2-6420661FE843Q30571548-8A362E9D-4B74-443F-BACB-39FAF77821B2Q30670043-3FD7D797-4FBB-44B3-90D1-C5ECFFAE57DFQ31008411-9F3B3E84-D203-4545-BD7A-81C516530068Q33238943-5C19760E-6EEE-4124-8581-DAA96C4DD5F1Q33307796-F8F80915-F2FA-4AF0-ACD1-795C5A1BB261Q33308479-C66CB9FB-2053-495E-9584-F97F887BCE74Q33424071-3A458438-FBAD-44B8-8D39-3FAEE44529E7Q33452667-52F78C45-E922-4318-8F0A-7B8B24C5AC09Q33525022-89401610-1C03-4D67-ADFD-1B91464AEB2AQ33552991-EC9CB391-1D70-47A7-804E-D7E9B5BE76A1Q33598454-8963DAD0-99DC-4D27-B563-B64A74D66964Q33783876-ABFCB34B-BEF6-462A-A78A-594E930591D3Q33788720-9A3C4830-8739-422F-906E-5DDDBB9AA2AAQ33898516-4009C631-53C0-4F15-ABBF-3BFF4568F39BQ33927314-FB88662D-6676-4D71-835E-4B4D4362A401
P2860
Chromosome 21 and down syndrome: from genomics to pathophysiology
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chromosome 21 and down syndrome: from genomics to pathophysiology
@ast
Chromosome 21 and down syndrome: from genomics to pathophysiology
@en
Chromosome 21 and down syndrome: from genomics to pathophysiology
@nl
type
label
Chromosome 21 and down syndrome: from genomics to pathophysiology
@ast
Chromosome 21 and down syndrome: from genomics to pathophysiology
@en
Chromosome 21 and down syndrome: from genomics to pathophysiology
@nl
prefLabel
Chromosome 21 and down syndrome: from genomics to pathophysiology
@ast
Chromosome 21 and down syndrome: from genomics to pathophysiology
@en
Chromosome 21 and down syndrome: from genomics to pathophysiology
@nl
P2093
P2860
P3181
P356
P1476
Chromosome 21 and down syndrome: from genomics to pathophysiology
@en
P2093
Emmanouil T Dermitzakis
Robert Lyle
Samuel Deutsch
P2860
P2888
P304
P3181
P356
10.1038/NRG1448
P407
P577
2004-10-01T00:00:00Z
P6179
1043277982